HISTOLOGY AND HISTOPATHOLOGY

Cellular and Molecular Biology

 

Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma

G-H. Piao1*, W-H. Piao2,3*, Y. He3, H-H. Zhang3, G-Q. Wang3 and Z. Piao4

1Department of Clinical Pathology, Yanbian Social Mental Hospital, Yanji City, China, 2Department of Physiology, Yanbian University, College of Medicine, Yanji City, China, 3Department of Infectious Disease, Peking University First Hospital, Beijing, China and 4Department of Pathology, Yanbian University, College of Medicine, Yanji City, China
*Drs. G-H. Piao and W-H. Piao contributed equally to this article.

Offprint requests to: Zhe Piao, MD, PhD, Dept. of Pathology, UCSD Medical Center, 200 West Arbor Dr., # 8320, San Diego, CA 92103. e-mail: zpiao@ucsd.edu


Summary. The retinoblastoma protein-interacting zinc finger gene RIZ1 is a putative tumor suppressor gene, and the inactivation of the RIZ1 is frequently found in tumors through a loss of mRNA expression. In order to understand the role of RIZ1 inactivation in the tumorigenesis of hepatocellular carcinoma (HCC), we detected the RIZ1 promoter methylation status in 39 HCCs using a methylation specific PCR (MSP) method, and carried out LOH study with marker P704. We also assessed the associations between the methylation status and clinicopathological parameters, tumor size, tumor differentiation, and fractional allelic loss (FAL). The results showed that the RIZ1 promoter methylated both in advanced tumors (>3 cm), (18/31, 58.0%) and in early tumors (<3 cm), (4/8, 50.0%). There were 54.6% (12/22) tumors with hyper-methylation in the low FAL group and 45.5% (10/22) in the high FAL group. Moreover, the DNA methylation of the RIZ1 promoter was found not only in the poorly differentiated tumors (12/22, 54.6%), but also in the well differentiated tumors (10/22, 45.5%). Among the 22 HCCs (22/39, 56.4%) that showed hyper-methylation at the RIZ1 promoter region, 3 cases showed biallelic methylation. Interestingly, one case showed hyper-methylation on one allele and a loss of heterozygosity (LOH) on the other allele. In other words, 4 HCCs showed the biallelic inactivation of the RIZ1. These results suggest that the inactivation of the RIZ1 by DNA methylation at its promoter region is involved in the tumorigenesis of HCC, particularly in the early stage of disease. Histol Histopathol 23, 1171-1175 (2008)

Key words: Hepatocellular carcinoma, Tumor suppressor gene, Methylation

DOI: 10.14670/HH-23.1171